NCT01285115

The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form

Phase 3 The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form : A Randomized, Double Blind, Parallel-controlled Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 147 (actual)
• Sponsor: Korea Health Industry Development Institute · Other Government
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Accepted

Summary

In this randomized, double blinded, Parallel-controlled study, the investigators planned to give Gamisoyosan extract, Gamisoyosan extract powder or controlled medication on Anxiety of generalized anxiety disorder according to dosage form.

Conditions

• Generalized Anxiety Disorder

Interventions

Type	Name	Description
DRUG	Placebo	AC 30 min, three times a day each sack taken before or between meals, 7.67g for each sack, 8 weeks.
DRUG	KyungBangn-Gamisoyosan-x-gwarip	AC 30 min, three times a day each sack taken before or between meals, 7.67g for each sack, 8 weeks.
DRUG	KyungBangn Gamisoyosan	AC 30 min, three times a day each sack taken before or between meals, 7.67g for each sack, 8 weeks.

Timeline

• Start date: 2008-12-01
• Primary completion: 2010-06-01
• Completion: 2010-07-01
• First posted: 2011-01-27
• Last updated: 2011-01-27

Locations

1 site across 1 country: South Korea